Aurinia Pharmaceuticals Inc. (AUPH) Form 10-K Annual Reports
Aurinia Pharmaceuticals Inc. (AUPH) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AUPH
CIK: 1600620
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerNeil Rostant
Audit LocationEdmonton, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-11 | 2026-09-10 | FORM 4 | 0001600620-26-000068 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-26 | — | SCHEDULE 13D/A Filing | 0001104659-26-101785 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0001837798-26-000013 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0001837798-26-000010 | View SEC Doc Filr Page |
| 8-K | 2026-08-19 | 2026-08-19 | 8-K | 0001600620-26-000066 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001600620-26-000062 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001600620-26-000059 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | FORM 4 | 0001370348-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | FORM 4 | 0001896369-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | FORM 4 | 0001302605-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | FORM 4 | 0001500210-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-06-05 | — | 144 Filing | 0001950047-26-005702 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-04 | — | SCHEDULE 13D/A Filing | 0001214659-26-007175 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-03 | 8-K | 0001600620-26-000053 | View SEC Doc Filr Page |
| 144 | 2026-06-04 | — | 144 Filing | 0001950047-26-005622 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-05-29 | 4 Filing | 0001178579-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-06-02 | — | 144 Filing | 0001950047-26-005481 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | FORM 4 | 0001837798-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | FORM 4 | 0001759910-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | FORM 4 | 0002126966-26-000003 | View SEC Doc Filr Page |
| 144 | 2026-05-11 | — | 144 Filing | 0001950047-26-004312 | View SEC Doc Filr Page |
| 144 | 2026-05-11 | — | 144 Filing | 0001950047-26-004310 | View SEC Doc Filr Page |
| 144 | 2026-05-11 | — | 144 Filing | 0001950047-26-004306 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-08 | 8-K | 0001140361-26-020402 | View SEC Doc Filr Page |
| SC TO-T/A | 2026-05-11 | — | SC TO-T/A | 0001140361-26-020397 | View SEC Doc Filr Page |